Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aldeyra Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- +8 vs. Q3 2022
- Shares held
- 34.2M
- −2.78M (−7.5%) vs. Q3 2022
- Total value
- $237.9M
- +$40.5M (+20.5%) vs. Q3 2022
- New holders
- 18
- 24 more added
- Sold out
- 10
- 36 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 107 | $77.7M |
| Q1 2026 | 128 | $63.3M |
| Q4 2025 | 136 | $201.8M |
| Q3 2025 | 131 | $204.2M |
| Q2 2025 | 122 | $130.8M |
| Q1 2025 | 126 | $215.5M |
| Q4 2024 | 119 | $185.6M |
| Q3 2024 | 112 | $196.4M |
| Q2 2024 | 103 | $116.9M |
| Q1 2024 | 101 | $115.8M |
| Q4 2023 | 105 | $123.3M |
| Q3 2023 | 120 | $252.3M |
| Q2 2023 | 119 | $327.5M |
| Q1 2023 | 109 | $353.4M |
| Q4 2022 | 96 | $237.9M |
| Q3 2022 | 89 | $197.4M |
| Q2 2022 | 95 | $147.5M |
| Q1 2022 | 111 | $171.8M |
| Q4 2021 | 115 | $146.7M |
| Q3 2021 | 117 | $348.9M |
| Q2 2021 | 136 | $512.8M |
| Q1 2021 | 108 | $376.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aldeyra Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CSS LLC | 0 | $0 | 0.00% | −26,828−100.0% | Sold out |
| Curi Capital | 0 | $0 | 0.00% | −21,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,573−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −17,138−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −12,025−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −6,754−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |